{
    "Trade/Device Name(s)": [
        "NoFact IX Deficient Plasma",
        "NoFact IX"
    ],
    "Submitter Information": "r2 Diagnostics, Inc.",
    "510(k) Number": "K102908",
    "Predicate Device Reference 510(k) Number(s)": [
        "K933432"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJT"
    ],
    "Summary Letter Date": "December 7, 2011",
    "Summary Letter Received Date": "December 8, 2011",
    "Submission Date": "November 15, 2010",
    "Regulation Number(s)": [
        "21 CFR 864.7290"
    ],
    "Regulation Name(s)": [
        "Factor Deficiency Test"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Factor IX"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "STA Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Activated partial thromboplastin time (APTT) assay"
    ],
    "Methodologies": [
        "Clotting time-based assay"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for NoFact IX Deficient Plasma, an immunodepleted human plasma reagent for quantitative determination of Factor IX activity.",
    "Indications for Use Summary": "Intended for quantitative determination of Factor IX activity in citrated plasma from patients suspected of FIX deficiency using APTT, for in vitro diagnostic use.",
    "fda_folder": "Hematology"
}